Latest filing published 12 Jun 2025 for Ironwood Pharmaceuticals INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Andrew Dreyfus: trading record in brief
Andrew Dreyfus, listed as board member, appears in our data through filings on Ironwood Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 22 filings, for trades running from 6 April 2016 to 10 June 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 12 June 2025 came the latest disclosure, a share grant in Ironwood Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew Dreyfus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,000 shares0Class A Common StockSEC:0000950170-25-085437:0
- 24,311 shares0Class A Common StockSEC:0000950170-24-076211:0
- 22,350 shares0Class A Common StockSEC:0001209191-23-039134:0
- 21,571 shares0Class A Common StockSEC:0001209191-22-033965:0
- 1,431 shares0Class A Common StockSEC:0001209191-21-070234:0
- 1,344 shares0Class A Common StockSEC:0001209191-21-056656:0
- 1,453 shares0Class A Common StockSEC:0001209191-21-040921:0
- 22,766 shares0Class A Common StockSEC:0001209191-21-038191:0
8 of 8 declarations
